---
title: "CURAUDEAU ALAIN — Ownership Dossier"
canonical: https://whiteintel.dev/entity/460ebc40-a45e-57b3-a3ee-ceaee3e0c447
json: https://whiteintel.dev/api/public/dossier/460ebc40-a45e-57b3-a3ee-ceaee3e0c447
identifier: sec:0001309651
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# CURAUDEAU ALAIN

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001309651`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/460ebc40-a45e-57b3-a3ee-ceaee3e0c447  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/460ebc40-a45e-57b3-a3ee-ceaee3e0c447  

## Ownership & control

### Holdings / subsidiaries

- **NOVELION THERAPEUTICS INC.** (officer) — https://whiteintel.dev/entity/f3d6a7ec-1c7e-5acd-bff3-e233da0facbe

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **CURAUDEAU ALAIN**. Human view: https://whiteintel.dev/entity/460ebc40-a45e-57b3-a3ee-ceaee3e0c447 · Structured JSON: https://whiteintel.dev/api/public/dossier/460ebc40-a45e-57b3-a3ee-ceaee3e0c447._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._